ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2,2,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
3,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
4,1,Oculogyric crisis,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
5,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
5,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
6,1,Alcoholic pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
6,2,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
7,1,Faecaloma,Faecal abnormalities NEC,Gastrointestinal signs and symptoms,Gastr,N
8,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
8,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
8,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
8,4,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
9,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
10,1,Extrapyramidal disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
11,1,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
11,2,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
12,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
12,2,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
13,1,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
14,1,Amenorrhoea,Menstruation with decreased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
14,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
14,3,Breast enlargement,Breast disorders NEC,Breast disorders,Repro,N
14,4,Galactorrhoea,Lactation disorders,Breast disorders,Repro,N
14,5,Myalgia,Muscle pains,Muscle disorders,Musc,N
15,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
15,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
15,3,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
16,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
17,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
17,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
18,1,Device leakage,Device issues NEC,Device issues,Prod,N
18,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
18,3,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
19,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
19,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
20,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
20,2,Orthostatic hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
21,1,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
22,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
22,2,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
23,1,Schizoaffective disorder,Schizoaffective and schizophreniform disorders,Schizophrenia and other psychotic disorders,Psych,N
24,1,Extrapyramidal disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
24,2,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
24,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
25,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
25,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
26,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
26,2,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
27,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
27,2,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
28,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
28,2,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
28,3,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
28,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
29,1,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
29,2,Procedural complication,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
30,1,Schizophrenia,Schizophrenia NEC,Schizophrenia and other psychotic disorders,Psych,N
30,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
31,1,Euphoric mood,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
31,2,Mania,Mood alterations with manic symptoms,Manic and bipolar mood disorders and disturbances,Psych,N
32,1,Gynaecomastia,Breast disorders NEC,Breast disorders,Repro,N
32,2,Hyperprolactinaemia,Anterior pituitary hyperfunction,Hypothalamus and pituitary gland disorders,Endo,N
33,1,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
34,1,Schizophrenia,Schizophrenia NEC,Schizophrenia and other psychotic disorders,Psych,N
35,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
36,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
37,1,Schizophrenia,Schizophrenia NEC,Schizophrenia and other psychotic disorders,Psych,N
38,1,Schizophrenia,Schizophrenia NEC,Schizophrenia and other psychotic disorders,Psych,N
39,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
39,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
39,3,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
39,4,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
39,5,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
40,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
40,2,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
41,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
41,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
41,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
42,1,Product administered at inappropriate site,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
42,2,Schizophrenia,Schizophrenia NEC,Schizophrenia and other psychotic disorders,Psych,N
43,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
43,2,Delusion,Delusional symptoms,Disturbances in thinking and perception,Psych,N
44,1,Schizophrenia,Schizophrenia NEC,Schizophrenia and other psychotic disorders,Psych,N
45,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
45,2,Alcohol abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
45,3,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
45,4,Mania,Mood alterations with manic symptoms,Manic and bipolar mood disorders and disturbances,Psych,N
45,5,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
46,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
46,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
46,3,Schizophrenia,Schizophrenia NEC,Schizophrenia and other psychotic disorders,Psych,N
47,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
48,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
48,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
48,3,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
49,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
50,1,Schizophrenia,Schizophrenia NEC,Schizophrenia and other psychotic disorders,Psych,N
51,1,Parkinson's disease,Parkinson's disease and parkinsonism,Movement disorders (incl parkinsonism),Nerv,N
52,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
53,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
54,1,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
54,2,Schizophrenia,Schizophrenia NEC,Schizophrenia and other psychotic disorders,Psych,N
55,1,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
56,1,Schizophrenia,Schizophrenia NEC,Schizophrenia and other psychotic disorders,Psych,N
57,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
58,1,Schizophrenia,Schizophrenia NEC,Schizophrenia and other psychotic disorders,Psych,N
59,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
59,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
60,1,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
60,2,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
61,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
62,1,Alcohol abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
63,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
64,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
64,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
64,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
64,4,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
64,5,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
64,6,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
65,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
65,2,Self-injurious ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
66,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
67,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
67,2,Mood altered,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
67,3,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
68,1,Amenorrhoea,Menstruation with decreased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
68,2,Breast tenderness,Breast signs and symptoms,Breast disorders,Repro,N
68,3,Hyperprolactinaemia,Anterior pituitary hyperfunction,Hypothalamus and pituitary gland disorders,Endo,N
69,1,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
70,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
71,1,Sudden death,Death and sudden death,Fatal outcomes,Genrl,Y
72,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
72,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
73,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
74,1,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
74,2,Hyperprolactinaemia,Anterior pituitary hyperfunction,Hypothalamus and pituitary gland disorders,Endo,N
75,1,"Hallucination, auditory",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
75,2,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
76,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
76,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
77,1,Schizophrenia,Schizophrenia NEC,Schizophrenia and other psychotic disorders,Psych,N
78,1,Schizophrenia,Schizophrenia NEC,Schizophrenia and other psychotic disorders,Psych,N
79,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
79,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
79,3,Feeling of body temperature change,Feelings and sensations NEC,General system disorders NEC,Genrl,N
79,4,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
79,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
79,6,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
79,7,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
80,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
81,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
81,2,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
82,1,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
83,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
83,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
84,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
84,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
85,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
85,2,Feeling of body temperature change,Feelings and sensations NEC,General system disorders NEC,Genrl,N
85,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
85,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
85,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
85,6,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
85,7,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
85,8,Sinusitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
85,9,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
86,1,Amenorrhoea,Menstruation with decreased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
86,2,Breast discomfort,Breast signs and symptoms,Breast disorders,Repro,N
86,3,Hyperprolactinaemia,Anterior pituitary hyperfunction,Hypothalamus and pituitary gland disorders,Endo,N
87,1,Breast mass,Breast disorders NEC,Breast disorders,Repro,N
87,2,Breast tenderness,Breast signs and symptoms,Breast disorders,Repro,N
87,3,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
87,4,Galactorrhoea,Lactation disorders,Breast disorders,Repro,N
87,5,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
87,6,Schizophrenia,Schizophrenia NEC,Schizophrenia and other psychotic disorders,Psych,N
88,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
88,2,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
89,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
89,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
90,1,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
90,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
90,3,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
91,1,Cystitis,Urinary tract infections,Infections - pathogen unspecified,Infec,N
91,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
91,3,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
92,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
93,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
93,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
93,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
93,4,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
93,5,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
94,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
95,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
95,2,Schizophrenia,Schizophrenia NEC,Schizophrenia and other psychotic disorders,Psych,N
96,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
96,2,Blood prolactin increased,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
96,3,Blood urine present,Urinalysis NEC,Renal and urinary tract investigations and urinalyses,Inv,N
96,4,Gynaecomastia,Breast disorders NEC,Breast disorders,Repro,N
96,5,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
96,6,Testicular pain,Testicular and epididymal disorders NEC,Testicular and epididymal disorders,Repro,N
97,1,Amenorrhoea,Menstruation with decreased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
97,2,Blood prolactin increased,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
97,3,Galactorrhoea,Lactation disorders,Breast disorders,Repro,N
97,4,Sexual dysfunction,Sexual function and fertility disorders NEC,Sexual function and fertility disorders,Repro,N
98,1,Extrapyramidal disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
99,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
99,2,Disinhibition,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
99,3,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
100,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
100,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
100,3,Disturbance in social behaviour,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
100,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
100,5,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
100,6,Road traffic accident,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
100,7,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
101,1,Schizophrenia,Schizophrenia NEC,Schizophrenia and other psychotic disorders,Psych,N
101,2,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
102,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
102,2,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
102,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
103,1,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
103,2,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
104,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
104,2,Schizophrenia,Schizophrenia NEC,Schizophrenia and other psychotic disorders,Psych,N
105,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
106,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
106,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
106,3,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
106,4,Injection site warmth,Injection site reactions,Administration site reactions,Genrl,N
106,5,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
107,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
107,2,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
107,3,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
108,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
109,1,Injection site abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
110,1,Completed suicide,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,Y
111,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
112,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
112,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
112,3,Hyperprolactinaemia,Anterior pituitary hyperfunction,Hypothalamus and pituitary gland disorders,Endo,N
112,4,Mental impairment,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
112,5,Psychotic behaviour,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
113,1,Angina pectoris,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
113,2,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
113,3,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
113,4,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
113,5,Ear discomfort,Ear disorders NEC,Aural disorders NEC,Ear,N
113,6,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
113,7,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
113,8,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
114,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
114,2,Extrapyramidal disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
114,3,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
115,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
116,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
116,2,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
117,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
117,2,Drug screen positive,Toxicology laboratory analyses,Toxicology and therapeutic drug monitoring,Inv,N
117,3,Indifference,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
117,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
117,5,Loss of personal independence in daily activities,Disability issues,Lifestyle issues,SocCi,N
118,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
119,1,Akathisia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
119,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
119,3,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
119,4,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
120,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
120,2,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
121,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
121,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
121,3,Extrapyramidal disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
122,1,Blood prolactin increased,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
122,2,Bradykinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
122,3,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
122,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
123,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
124,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
124,2,Schizophrenia,Schizophrenia NEC,Schizophrenia and other psychotic disorders,Psych,N
125,1,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
125,2,Schizophrenia,Schizophrenia NEC,Schizophrenia and other psychotic disorders,Psych,N
126,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
126,2,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
126,3,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
127,1,Tardive dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
128,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
128,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
128,3,"Hallucination, auditory",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
128,4,Self-destructive behaviour,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
129,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
130,1,Delusion,Delusional symptoms,Disturbances in thinking and perception,Psych,N
131,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
132,1,Blood prolactin increased,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
132,2,Gynaecomastia,Breast disorders NEC,Breast disorders,Repro,N
133,1,Priapism,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
134,1,Ejaculation failure,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
135,1,Blood prolactin increased,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
135,2,Galactorrhoea,Lactation disorders,Breast disorders,Repro,N
136,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
137,1,Blood prolactin increased,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
138,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
138,2,Akathisia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
138,3,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
138,4,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
139,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
139,2,Pustule,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
139,3,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
140,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
141,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
141,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
142,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
142,2,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
143,1,Akathisia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
143,2,Extrapyramidal disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
143,3,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
143,4,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
144,1,Mania,Mood alterations with manic symptoms,Manic and bipolar mood disorders and disturbances,Psych,N
145,1,Cardiovascular disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
145,2,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
146,1,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
146,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
146,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
146,4,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
146,5,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
146,6,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
146,7,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
146,8,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
147,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
147,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
147,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
147,4,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
148,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
148,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
148,3,Suicide attempt,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
149,1,Atrioventricular block first degree,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
150,1,Blood prolactin increased,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
150,2,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
150,3,Tardive dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
151,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
152,1,Galactorrhoea,Lactation disorders,Breast disorders,Repro,N
153,1,Amenorrhoea,Menstruation with decreased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
153,2,Breast tenderness,Breast signs and symptoms,Breast disorders,Repro,N
153,3,Hyperprolactinaemia,Anterior pituitary hyperfunction,Hypothalamus and pituitary gland disorders,Endo,N
154,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
154,2,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
154,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
155,1,Galactorrhoea,Lactation disorders,Breast disorders,Repro,N
155,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
156,1,Blood prolactin increased,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
156,2,Galactorrhoea,Lactation disorders,Breast disorders,Repro,N
156,3,Local reaction,General signs and symptoms NEC,General system disorders NEC,Genrl,N
157,1,Amenorrhoea,Menstruation with decreased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
157,2,Galactorrhoea,Lactation disorders,Breast disorders,Repro,N
158,1,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
159,1,Hypoprolactinaemia,Anterior pituitary hypofunction,Hypothalamus and pituitary gland disorders,Endo,N
160,1,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
161,1,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
161,2,"Hallucination, auditory",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
162,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
163,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
163,2,Dystonia,Dystonias,Movement disorders (incl parkinsonism),Nerv,N
164,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
164,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
164,3,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
164,4,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
165,1,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
165,2,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
165,3,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
166,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
167,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
167,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
168,1,Extrapyramidal disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
169,1,Akathisia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
169,2,Extrapyramidal disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
170,1,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
170,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
170,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
170,4,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
170,5,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
170,6,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
170,7,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
170,8,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
171,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
171,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
171,3,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
172,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
173,1,Urine output increased,Urinary tract function analyses NEC,Renal and urinary tract investigations and urinalyses,Inv,N
173,2,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
174,1,Schizophrenia,Schizophrenia NEC,Schizophrenia and other psychotic disorders,Psych,N
175,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
175,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
175,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
176,1,Cutaneous vasculitis,Skin vasculitides,Skin vascular abnormalities,Skin,N
177,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
177,2,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
178,1,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
178,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
178,3,Mean cell volume decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
179,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
179,2,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
179,3,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
180,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,Y
180,2,Respiratory disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
181,1,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
181,2,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
181,3,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
182,1,"Hallucination, auditory",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
182,2,Loss of libido,Sexual desire disorders,"Sexual dysfunctions, disturbances and gender identity disorders",Psych,N
182,3,Morbid thoughts,Thinking disturbances,Disturbances in thinking and perception,Psych,N
182,4,Schizophrenia,Schizophrenia NEC,Schizophrenia and other psychotic disorders,Psych,N
183,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
183,2,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
183,3,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
183,4,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
183,5,Hepatitis C,Hepatitis virus infections,Viral infectious disorders,Infec,N
183,6,Hostility,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
183,7,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
183,8,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
183,9,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
184,1,Corneal reflex decreased,Ophthalmic function diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
184,2,Dystonia,Dystonias,Movement disorders (incl parkinsonism),Nerv,N
184,3,Grunting,Breathing abnormalities,Respiratory disorders NEC,Resp,N
185,1,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
185,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
186,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
186,2,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
187,1,Amenorrhoea,Menstruation with decreased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
187,2,Blood prolactin increased,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
188,1,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
188,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
189,1,Parkinsonism,Parkinson's disease and parkinsonism,Movement disorders (incl parkinsonism),Nerv,N
190,1,Akathisia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
191,1,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
192,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
192,2,Headache,Headaches NEC,Headaches,Nerv,N
193,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
193,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
193,3,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
194,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
195,1,Sexual activity increased,Sexuality issues,Gender related factors,SocCi,N
196,1,Galactorrhoea,Lactation disorders,Breast disorders,Repro,N
197,1,Akathisia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
197,2,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
197,3,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
198,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
199,1,Akathisia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
200,1,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
201,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
201,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
201,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
202,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
203,1,Mania,Mood alterations with manic symptoms,Manic and bipolar mood disorders and disturbances,Psych,N
204,1,Ejaculation disorder,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
205,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
205,2,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
205,3,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
205,4,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
205,5,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
205,6,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
205,7,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
206,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
206,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
206,3,Unintended pregnancy,Unintended pregnancies,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
207,1,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
208,1,Nasal congestion,Nasal congestion and inflammations,Upper respiratory tract disorders (excl infections),Resp,N
208,2,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
208,3,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
209,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
210,1,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
210,2,Thrombophlebitis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
211,1,Blood prolactin increased,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
212,1,Injection site nodule,Injection site reactions,Administration site reactions,Genrl,N
212,2,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
213,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
213,2,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
213,3,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
214,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
214,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
214,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
214,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
214,5,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
214,6,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
215,1,Myalgia,Muscle pains,Muscle disorders,Musc,N
215,2,Myosclerosis,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
216,1,Schizophrenia,Schizophrenia NEC,Schizophrenia and other psychotic disorders,Psych,N
217,1,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
218,1,Akathisia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
218,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
219,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
220,1,Acute left ventricular failure,Left ventricular failures,Heart failures,Card,N
220,2,Coronary artery disease,Coronary artery disorders NEC,Coronary artery disorders,Card,N
220,3,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
221,1,Joint stiffness,Joint related signs and symptoms,Joint disorders,Musc,N
221,2,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
221,3,Oromandibular dystonia,Dystonias,Movement disorders (incl parkinsonism),Nerv,N
221,4,Pain in jaw,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
221,5,Trismus,Muscle tone abnormalities,Muscle disorders,Musc,N
222,1,Blood prolactin increased,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
223,1,Diabetic ketoacidosis,Diabetic complications NEC,Diabetic complications,Metab,N
223,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
224,1,Galactorrhoea,Lactation disorders,Breast disorders,Repro,N
224,2,Hyperprolactinaemia,Anterior pituitary hyperfunction,Hypothalamus and pituitary gland disorders,Endo,N
225,1,Hyperprolactinaemia,Anterior pituitary hyperfunction,Hypothalamus and pituitary gland disorders,Endo,N
226,1,Amenorrhoea,Menstruation with decreased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
226,2,Blood prolactin increased,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
226,3,Galactorrhoea,Lactation disorders,Breast disorders,Repro,N
227,1,Blood prolactin increased,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
228,1,Akathisia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
228,2,Emotional poverty,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
228,3,Glassy eyes,General signs and symptoms NEC,General system disorders NEC,Genrl,N
228,4,Sedation complication,Anaesthetic and allied procedural complications,Procedural related injuries and complications NEC,Inj&P,N
228,5,Staring,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
229,1,Akathisia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
230,1,Urinary incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
230,2,Vaginal prolapse,Pelvic prolapse conditions,"Uterine, pelvic and broad ligament disorders",Repro,N
231,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
231,2,Extrapyramidal disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
232,1,Blood prolactin increased,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
232,2,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
232,3,Trismus,Muscle tone abnormalities,Muscle disorders,Musc,N
233,1,Extrapyramidal disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
233,2,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
234,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
234,2,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
234,3,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
235,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
236,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
236,2,Haemorrhage in pregnancy,Haemorrhagic complications of pregnancy,Maternal complications of pregnancy,Preg,N
236,3,Oligohydramnios,Amniotic fluid and cavity disorders of pregnancy NEC,"Placental, amniotic and cavity disorders (excl haemorrhages)",Preg,N
237,1,Foetal disorder,Foetal complications NEC,Foetal complications,Preg,Y
238,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
238,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
239,1,Nasal congestion,Nasal congestion and inflammations,Upper respiratory tract disorders (excl infections),Resp,N
240,1,Akathisia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
240,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
240,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
241,1,Tardive dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
241,2,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
242,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
242,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
243,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
244,1,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
244,2,Schizophrenia,Schizophrenia NEC,Schizophrenia and other psychotic disorders,Psych,N
245,1,Amenorrhoea,Menstruation with decreased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
245,2,Hirsutism,Hypertrichoses,Skin appendage conditions,Skin,N
245,3,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
246,1,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
247,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
248,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
248,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
249,1,Amenorrhoea,Menstruation with decreased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
249,2,Galactorrhoea,Lactation disorders,Breast disorders,Repro,N
249,3,Hyperprolactinaemia,Anterior pituitary hyperfunction,Hypothalamus and pituitary gland disorders,Endo,N
250,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
250,2,Mental impairment,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
251,1,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
251,2,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
252,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
252,2,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
252,3,Restless legs syndrome,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
252,4,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
253,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
253,2,Headache,Headaches NEC,Headaches,Nerv,N
253,3,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
254,1,Amenorrhoea,Menstruation with decreased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
254,2,Hyperprolactinaemia,Anterior pituitary hyperfunction,Hypothalamus and pituitary gland disorders,Endo,N
254,3,Underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
254,4,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
255,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
256,1,Breast mass,Breast disorders NEC,Breast disorders,Repro,N
257,1,Blood prolactin increased,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
257,2,Gynaecomastia,Breast disorders NEC,Breast disorders,Repro,N
258,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
258,2,Parkinsonism,Parkinson's disease and parkinsonism,Movement disorders (incl parkinsonism),Nerv,N
259,1,Blood prolactin increased,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
260,1,Dystonia,Dystonias,Movement disorders (incl parkinsonism),Nerv,N
261,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
261,2,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
262,1,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
262,2,Head injury,Site specific injuries NEC,Injuries NEC,Inj&P,N
262,3,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
262,4,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
262,5,Water intoxication,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
263,1,"Hallucination, auditory",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
263,2,Mental impairment,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
264,1,Blood prolactin increased,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
264,2,Sexual dysfunction,Sexual function and fertility disorders NEC,Sexual function and fertility disorders,Repro,N
265,1,"Hallucination, auditory",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
266,1,"Hallucination, auditory",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
267,1,Coma scale abnormal,Neurologic diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
267,2,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
268,1,Extrapyramidal disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
269,1,Extrapyramidal disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
269,2,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
270,1,Extrapyramidal disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
270,2,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
270,3,Sexual dysfunction,Sexual function and fertility disorders NEC,Sexual function and fertility disorders,Repro,N
270,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
271,1,"Delusional disorder, unspecified type",Delusional disorders,Schizophrenia and other psychotic disorders,Psych,N
271,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
271,3,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
271,4,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
272,1,Coma,Coma states,Neurological disorders NEC,Nerv,N
272,2,Hypothermia,Body temperature altered,Body temperature conditions,Genrl,N
272,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
273,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
273,2,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
273,3,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
274,1,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
275,1,Priapism,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
276,1,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
277,1,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
278,1,Hyperprolactinaemia,Anterior pituitary hyperfunction,Hypothalamus and pituitary gland disorders,Endo,N
279,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
280,1,Blood prolactin increased,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
280,2,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
280,3,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
280,4,Mental impairment,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
280,5,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
280,6,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
281,1,Extrapyramidal disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
281,2,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
281,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
282,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
283,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
284,1,Extrapyramidal disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
284,2,Neuroleptic malignant syndrome,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
285,1,Schizophrenia,Schizophrenia NEC,Schizophrenia and other psychotic disorders,Psych,N
286,1,Extrapyramidal disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
287,1,Neuroleptic malignant syndrome,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
288,1,Schizophrenia,Schizophrenia NEC,Schizophrenia and other psychotic disorders,Psych,N
289,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
289,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
290,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
290,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
291,1,Extrapyramidal disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
292,1,Social avoidant behaviour,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
292,2,Tearfulness,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
293,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
294,1,Amenorrhoea,Menstruation with decreased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
294,2,Blood prolactin increased,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
294,3,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
294,4,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
294,5,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
294,6,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
295,1,Blood prolactin increased,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
295,2,Galactorrhoea,Lactation disorders,Breast disorders,Repro,N
296,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
296,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
296,3,Type 1 diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
296,4,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
297,1,Sexual dysfunction,Sexual function and fertility disorders NEC,Sexual function and fertility disorders,Repro,N
298,1,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
298,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
298,3,Injection site warmth,Injection site reactions,Administration site reactions,Genrl,N
299,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
300,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
300,2,Disinhibition,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
300,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
300,4,Euphoric mood,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
301,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
301,2,Suicide attempt,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
302,1,Priapism,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
303,1,Blood prolactin increased,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
304,1,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
305,1,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
305,2,Injection site inflammation,Injection site reactions,Administration site reactions,Genrl,N
305,3,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
306,1,Akathisia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
306,2,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
306,3,Restless legs syndrome,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
306,4,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
307,1,Apathy,Mood disorders NEC,Mood disorders and disturbances NEC,Psych,N
307,2,"Hallucination, auditory",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
307,3,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
308,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
309,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
309,2,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
309,3,Sedation,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
309,4,Tension,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
309,5,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
310,1,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
311,1,Glycosylated haemoglobin increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
311,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
312,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
313,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
313,2,Akathisia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
313,3,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
313,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
314,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
314,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
315,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
315,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
316,1,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
317,1,Hyperprolactinaemia,Anterior pituitary hyperfunction,Hypothalamus and pituitary gland disorders,Endo,N
318,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
319,1,Extrapyramidal disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
320,1,Injection site induration,Injection site reactions,Administration site reactions,Genrl,N
320,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
321,1,Blood prolactin increased,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
321,2,Parkinsonism,Parkinson's disease and parkinsonism,Movement disorders (incl parkinsonism),Nerv,N
321,3,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
321,4,Tearfulness,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
322,1,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
323,1,Tardive dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
324,1,Dystonia,Dystonias,Movement disorders (incl parkinsonism),Nerv,N
325,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
325,2,Nodule,Mass conditions NEC,Tissue disorders NEC,Genrl,N
326,1,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
327,1,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
327,2,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
328,1,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
329,1,Cyst,Mass conditions NEC,Tissue disorders NEC,Genrl,N
329,2,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
329,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
330,1,Injection site induration,Injection site reactions,Administration site reactions,Genrl,N
330,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
331,1,Delusion,Delusional symptoms,Disturbances in thinking and perception,Psych,N
332,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
333,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
334,1,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
335,1,Angle closure glaucoma,Glaucomas (excl congenital),Glaucoma and ocular hypertension,Eye,N
335,2,Headache,Headaches NEC,Headaches,Nerv,N
335,3,Intraocular pressure increased,Ophthalmic function diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
335,4,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
335,5,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
336,1,Hysterectomy,Uterine therapeutic procedures,Obstetric and gynaecological therapeutic procedures,Surg,N
336,2,Intraocular pressure increased,Ophthalmic function diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
336,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
336,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
337,1,Extrapyramidal disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
337,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
337,3,Oculogyric crisis,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
338,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
338,2,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
339,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
339,2,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
340,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
340,2,Completed suicide,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,Y
340,3,Injury,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
340,4,Skin laceration,Skin injuries NEC,Injuries NEC,Inj&P,N
341,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
342,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
342,2,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
343,1,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
344,1,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
344,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
344,3,Schizoaffective disorder,Schizoaffective and schizophreniform disorders,Schizophrenia and other psychotic disorders,Psych,N
345,1,Nocturia,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
345,2,Schizophrenia,Schizophrenia NEC,Schizophrenia and other psychotic disorders,Psych,N
346,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
346,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
347,1,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
348,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
349,1,Oculogyric crisis,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
350,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
350,2,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
351,1,Catatonia,Decreased physical activity levels,Changes in physical activity,Psych,N
351,2,Delirium,Deliria,Deliria (incl confusion),Psych,N
352,1,Amenorrhoea,Menstruation with decreased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
352,2,Blood prolactin increased,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
352,3,Extrapyramidal disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
353,1,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
354,1,Restless legs syndrome,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
354,2,Skin mass,Skin and subcutaneous conditions NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
354,3,Somnambulism,Parasomnias,Sleep disorders and disturbances,Psych,N
355,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
355,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
355,3,Hypertonia,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
355,4,Parkinsonism,Parkinson's disease and parkinsonism,Movement disorders (incl parkinsonism),Nerv,N
355,5,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
355,6,Sexual dysfunction,Sexual function and fertility disorders NEC,Sexual function and fertility disorders,Repro,N
356,1,Amenorrhoea,Menstruation with decreased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
356,2,Galactorrhoea,Lactation disorders,Breast disorders,Repro,N
356,3,Hyperprolactinaemia,Anterior pituitary hyperfunction,Hypothalamus and pituitary gland disorders,Endo,N
356,4,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
356,5,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
357,1,Blood prolactin abnormal,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
357,2,Loss of libido,Sexual desire disorders,"Sexual dysfunctions, disturbances and gender identity disorders",Psych,N
357,3,Premature ejaculation,Orgasmic disorders and disturbances,"Sexual dysfunctions, disturbances and gender identity disorders",Psych,N
357,4,Sexual dysfunction,Sexual function and fertility disorders NEC,Sexual function and fertility disorders,Repro,N
358,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
358,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
359,1,Chronic kidney disease,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
359,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
359,3,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
359,4,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
360,1,Injection site irritation,Injection site reactions,Administration site reactions,Genrl,N
360,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
360,3,Myalgia,Muscle pains,Muscle disorders,Musc,N
361,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
361,2,Extrapyramidal disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
362,1,Extrapyramidal disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
362,2,Headache,Headaches NEC,Headaches,Nerv,N
362,3,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
362,4,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
362,5,Tardive dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
363,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
364,1,Amenorrhoea,Menstruation with decreased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
365,1,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
366,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
367,1,Bronchitis,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
367,2,Emphysema,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
368,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
368,2,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
369,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
369,2,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
370,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
370,2,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
371,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
371,2,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
372,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
373,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
374,1,Amenorrhoea,Menstruation with decreased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
374,2,Blood prolactin increased,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
375,1,Amenorrhoea,Menstruation with decreased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
375,2,Blood prolactin increased,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
376,1,Amenorrhoea,Menstruation with decreased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
376,2,Blood prolactin increased,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
376,3,Loss of libido,Sexual desire disorders,"Sexual dysfunctions, disturbances and gender identity disorders",Psych,N
377,1,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
377,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
377,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
378,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
378,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
379,1,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
380,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
380,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
381,1,Blood prolactin increased,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
382,1,"Hallucination, auditory",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
382,2,Injection site discomfort,Injection site reactions,Administration site reactions,Genrl,N
382,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
382,4,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
382,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
383,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
383,2,"Hallucination, auditory",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
384,1,Cardiac valve disease,Cardiac valve disorders NEC,Cardiac valve disorders,Card,Y
385,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
386,1,Hyperprolactinaemia,Anterior pituitary hyperfunction,Hypothalamus and pituitary gland disorders,Endo,N
386,2,Schizophrenia,Schizophrenia NEC,Schizophrenia and other psychotic disorders,Psych,N
387,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
387,2,Injection site infection,Infections NEC,Infections - pathogen unspecified,Infec,N
387,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
387,4,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
388,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
388,2,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
388,3,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
388,4,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
388,5,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
388,6,Liver disorder,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
388,7,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
388,8,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
388,9,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
388,10,Pseudoparalysis,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
388,11,Reaction to excipient,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
388,12,Tendon disorder,Tendon disorders,"Tendon, ligament and cartilage disorders",Musc,N
389,1,Akathisia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
389,2,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
390,1,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
391,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
391,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
391,3,Posterior reversible encephalopathy syndrome,Encephalopathies NEC,Encephalopathies,Nerv,N
391,4,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
391,5,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
392,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
392,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
393,1,Breast cancer recurrent,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
393,2,Metastatic neoplasm,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
393,3,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
394,1,Injection site cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
395,1,Blood prolactin increased,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
395,2,Refusal of treatment by patient,Social issues NEC,Lifestyle issues,SocCi,N
396,1,Blood prolactin increased,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
396,2,Gynaecomastia,Breast disorders NEC,Breast disorders,Repro,N
397,1,Obsessive-compulsive disorder,Obsessive-compulsive disorders and symptoms,Anxiety disorders and symptoms,Psych,N
398,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
398,2,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
398,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
399,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
399,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
400,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
400,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
401,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
402,1,Completed suicide,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,Y
403,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
403,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
403,3,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
404,1,Tardive dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
405,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
405,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
406,1,Blood prolactin increased,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
406,2,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
407,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
408,1,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
408,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
408,3,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
409,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
409,2,Drug abuser,Drug and chemical abuse,Lifestyle issues,SocCi,N
409,3,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
410,1,Blood prolactin increased,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
410,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
410,3,Ejaculation disorder,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
410,4,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
411,1,Akathisia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
411,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
411,3,Motor dysfunction,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
412,1,Abnormal dreams,Parasomnias,Sleep disorders and disturbances,Psych,N
412,2,Amenorrhoea,Menstruation with decreased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
412,3,Sedation,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
412,4,Superovulation,Ovarian and fallopian tube disorders NEC,Ovarian and fallopian tube disorders,Repro,N
413,1,Tardive dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
414,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
414,2,Physical assault,Criminal activity,Legal issues,SocCi,N
415,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
415,2,Extrapyramidal disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
415,3,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
416,1,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
416,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
416,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
416,4,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
416,5,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
416,6,Hypertonia,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
416,7,Torticollis,Muscle tone abnormalities,Muscle disorders,Musc,N
417,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
417,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
418,1,Schizophrenia,Schizophrenia NEC,Schizophrenia and other psychotic disorders,Psych,N
419,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,Y
420,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
420,2,Blood prolactin increased,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
421,1,Blood prolactin increased,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
422,1,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
423,1,Anger,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
424,1,Anger,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
425,1,Injection site nodule,Injection site reactions,Administration site reactions,Genrl,N
426,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
426,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
427,1,Injection site nodule,Injection site reactions,Administration site reactions,Genrl,N
428,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
429,1,Extrapyramidal disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
429,2,Muscle rigidity,Muscle tone abnormalities,Muscle disorders,Musc,N
429,3,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
430,1,Blood prolactin increased,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
431,1,Blood prolactin increased,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
431,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
431,3,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
432,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
432,2,Altered state of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
432,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
433,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
434,1,Bipolar disorder,Bipolar disorders,Manic and bipolar mood disorders and disturbances,Psych,N
434,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
434,3,Refusal of treatment by patient,Social issues NEC,Lifestyle issues,SocCi,N
435,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
435,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
435,3,Poor quality sleep,Dyssomnias,Sleep disorders and disturbances,Psych,N
436,1,Dizziness postural,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
436,2,Headache,Headaches NEC,Headaches,Nerv,N
437,1,Hypertonia,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
437,2,Hypokinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
437,3,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
438,1,Blood prolactin increased,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
438,2,Blood testosterone decreased,Reproductive hormone analyses,Endocrine investigations (incl sex hormones),Inv,N
438,3,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
438,4,Libido decreased,Sexual desire disorders,"Sexual dysfunctions, disturbances and gender identity disorders",Psych,N
439,1,Mental impairment,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
440,1,Tardive dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
441,1,Hyperprolactinaemia,Anterior pituitary hyperfunction,Hypothalamus and pituitary gland disorders,Endo,N
442,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
442,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
442,3,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
442,4,Myalgia,Muscle pains,Muscle disorders,Musc,N
443,1,Amenorrhoea,Menstruation with decreased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
443,2,Hyperprolactinaemia,Anterior pituitary hyperfunction,Hypothalamus and pituitary gland disorders,Endo,N
444,1,Schizophrenia,Schizophrenia NEC,Schizophrenia and other psychotic disorders,Psych,N
445,1,Pulmonary thrombosis,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
446,1,Pulmonary thrombosis,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
447,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
447,2,"Hallucination, auditory",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
447,3,Intentional self-injury,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
447,4,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
448,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
449,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
449,2,Hypokinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
449,3,Skin infection,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
449,4,Skin mass,Skin and subcutaneous conditions NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
450,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
451,1,Injection site infection,Infections NEC,Infections - pathogen unspecified,Infec,N
451,2,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
451,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
452,1,Tonsillar hypertrophy,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
453,1,Blood prolactin increased,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
453,2,Breast discomfort,Breast signs and symptoms,Breast disorders,Repro,N
453,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
453,4,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
454,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
454,2,Schizophrenia,Schizophrenia NEC,Schizophrenia and other psychotic disorders,Psych,N
455,1,Akathisia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
456,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
456,2,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
457,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
457,2,Self-destructive behaviour,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
458,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
458,2,Symphysiolysis,Ligament disorders,"Tendon, ligament and cartilage disorders",Musc,N
458,3,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
459,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
460,1,Blood prolactin increased,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
460,2,Galactorrhoea,Lactation disorders,Breast disorders,Repro,N
460,3,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
461,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
462,1,Cardiac failure acute,Heart failures NEC,Heart failures,Card,Y
463,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
463,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
464,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
465,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
465,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
465,3,Product administered at inappropriate site,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
465,4,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
466,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
466,2,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
466,3,Injection site warmth,Injection site reactions,Administration site reactions,Genrl,N
467,1,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
468,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
468,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
468,3,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
469,1,Intentional self-injury,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
469,2,Suicide attempt,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
470,1,Blood prolactin increased,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
471,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
472,1,Bundle branch block right,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
472,2,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
473,1,Blood prolactin increased,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
473,2,Sexual dysfunction,Sexual function and fertility disorders NEC,Sexual function and fertility disorders,Repro,N
473,3,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
474,1,Gluten sensitivity,Food malabsorption and intolerance syndromes (excl sugar intolerance),Food intolerance syndromes,Metab,N
475,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
476,1,Enuresis,Psychiatric elimination disorders,Psychiatric disorders NEC,Psych,N
476,2,Extrapyramidal disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
476,3,Eyelid disorder,Ocular disorders NEC,Eye disorders NEC,Eye,N
476,4,Sedation complication,Anaesthetic and allied procedural complications,Procedural related injuries and complications NEC,Inj&P,N
476,5,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
477,1,Mental status changes,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
478,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
479,1,Tardive dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
480,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
481,1,Dystonia,Dystonias,Movement disorders (incl parkinsonism),Nerv,N
482,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
483,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
483,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
483,3,Psychotic behaviour,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
483,4,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
484,1,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
484,2,Schizophrenia,Schizophrenia NEC,Schizophrenia and other psychotic disorders,Psych,N
485,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
485,2,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
485,3,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
485,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
485,5,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
486,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
486,2,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
486,3,Mental impairment,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
486,4,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
486,5,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
487,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
487,2,Necrotising fasciitis,Muscle and soft tissue infections,Infections - pathogen unspecified,Infec,N
487,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
487,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
487,5,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
487,6,Streptococcal infection,Streptococcal infections,Bacterial infectious disorders,Infec,N
488,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
488,2,Cystitis,Urinary tract infections,Infections - pathogen unspecified,Infec,N
488,3,Death,Death and sudden death,Fatal outcomes,Genrl,Y
488,4,Heart valve incompetence,Cardiac valve disorders NEC,Cardiac valve disorders,Card,N
488,5,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
488,6,Impaired quality of life,Social issues NEC,Lifestyle issues,SocCi,N
488,7,Muscle contracture,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
488,8,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
488,9,Parkinsonism,Parkinson's disease and parkinsonism,Movement disorders (incl parkinsonism),Nerv,N
488,10,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
488,11,Sinus node dysfunction,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
488,12,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
489,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
489,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
490,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
491,1,Abnormal weight gain,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
491,2,Male sexual dysfunction,Sexual function and fertility disorders NEC,Sexual function and fertility disorders,Repro,N
491,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
492,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
493,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
493,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
493,3,Feeling of despair,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
493,4,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
493,5,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
494,1,Extrapyramidal disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
494,2,Headache,Headaches NEC,Headaches,Nerv,N
495,1,Injection site infection,Infections NEC,Infections - pathogen unspecified,Infec,N
495,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
495,3,Injection site pustule,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
495,4,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
496,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
496,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
497,1,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
498,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
498,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
498,3,Inappropriate affect,Affect alterations NEC,Mood disorders and disturbances NEC,Psych,N
498,4,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
498,5,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
499,1,Priapism,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
500,1,Orthostatic hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
501,1,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
501,2,Necrosis,Necrosis NEC,Tissue disorders NEC,Genrl,N
501,3,Priapism,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
502,1,Torticollis,Muscle tone abnormalities,Muscle disorders,Musc,N
503,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
504,1,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
504,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
505,1,Eye movement disorder,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
505,2,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
506,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
506,2,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
506,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
506,4,Sensory disturbance,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
507,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
507,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
508,1,Ectopic pregnancy,Maternal complications of pregnancy NEC,Maternal complications of pregnancy,Preg,N
508,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
509,1,Abnormal loss of weight,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
509,2,Agranulocytosis,Neutropenias,White blood cell disorders,Blood,N
509,3,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
509,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
510,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
511,1,Suicide attempt,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
511,2,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
512,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
512,2,Mental impairment,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
513,1,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
514,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
514,2,Facial paresis,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
514,3,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
514,4,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
515,1,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
515,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
515,3,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
516,1,Blood prolactin increased,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
517,1,Drug level decreased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
517,2,Mental impairment,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
517,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
517,4,Tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
518,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
518,2,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
518,3,Schizophrenia,Schizophrenia NEC,Schizophrenia and other psychotic disorders,Psych,N
519,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
519,2,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
519,3,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
519,4,Wound secretion,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
520,1,Sudden death,Death and sudden death,Fatal outcomes,Genrl,Y
521,1,Injection site induration,Injection site reactions,Administration site reactions,Genrl,N
522,1,Blood prolactin increased,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
522,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
523,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
523,2,Transient ischaemic attack,Transient cerebrovascular events,Central nervous system vascular disorders,Nerv,N
524,1,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
524,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
525,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
525,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
525,3,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
525,4,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
525,5,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
525,6,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
525,7,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
525,8,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
525,9,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
525,10,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
525,11,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
526,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
527,1,Priapism,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
528,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
529,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
529,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
529,3,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
529,4,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
529,5,Suicide attempt,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
530,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
531,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
531,2,Neuroleptic malignant syndrome,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
532,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
532,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
532,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
532,4,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
532,5,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
532,6,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
532,7,Mastication disorder,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
532,8,Nasal congestion,Nasal congestion and inflammations,Upper respiratory tract disorders (excl infections),Resp,N
532,9,Pharyngeal inflammation,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
532,10,Salivary hypersecretion,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
532,11,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
532,12,Urinary incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
532,13,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
533,1,Acute respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
534,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
535,1,Amenorrhoea,Menstruation with decreased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
535,2,Blood prolactin increased,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
535,3,Galactorrhoea,Lactation disorders,Breast disorders,Repro,N
536,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
536,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
536,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
536,4,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
536,5,Muscle atrophy,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
536,6,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
536,7,Scar,Skin injuries NEC,Injuries NEC,Inj&P,N
536,8,Sedation,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
536,9,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
536,10,Skin odour abnormal,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
536,11,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
536,12,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
536,13,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
537,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
537,2,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
538,1,Blood prolactin increased,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
539,1,Abscess limb,Infections NEC,Infections - pathogen unspecified,Infec,N
539,2,Cyst,Mass conditions NEC,Tissue disorders NEC,Genrl,N
539,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
540,1,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
540,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
540,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
540,4,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
540,5,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
541,1,Chronic kidney disease,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
541,2,Glomerular filtration rate increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
542,1,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
542,2,Schizophrenia,Schizophrenia NEC,Schizophrenia and other psychotic disorders,Psych,N
543,1,Enuresis,Psychiatric elimination disorders,Psychiatric disorders NEC,Psych,N
544,1,Retrograde ejaculation,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
545,1,Abnormal weight gain,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
545,2,Amenorrhoea,Menstruation with decreased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
545,3,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
545,4,Galactorrhoea,Lactation disorders,Breast disorders,Repro,N
545,5,Impulsive behaviour,Impulse control disorders,Impulse control disorders NEC,Psych,N
545,6,Lactation puerperal increased,Lactation disorders,Breast disorders,Repro,N
545,7,Mental impairment,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
546,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
546,2,Schizophrenia,Schizophrenia NEC,Schizophrenia and other psychotic disorders,Psych,N
547,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
548,1,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
549,1,Injection site discomfort,Injection site reactions,Administration site reactions,Genrl,N
549,2,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
549,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
550,1,Cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
551,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
552,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
553,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
553,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
553,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
553,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
553,5,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
554,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
554,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
555,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
555,2,Blood prolactin increased,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
556,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
557,1,Blood prolactin increased,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
558,1,Priapism,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
559,1,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
560,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
560,2,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
560,3,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
560,4,Poor quality sleep,Dyssomnias,Sleep disorders and disturbances,Psych,N
560,5,Schizophrenia,Schizophrenia NEC,Schizophrenia and other psychotic disorders,Psych,N
560,6,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
561,1,Akathisia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
561,2,Dry throat,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
561,3,Obsessive-compulsive disorder,Obsessive-compulsive disorders and symptoms,Anxiety disorders and symptoms,Psych,N
561,4,Oculogyric crisis,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
561,5,Respiratory distress,Breathing abnormalities,Respiratory disorders NEC,Resp,N
562,1,Rebound psychosis,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
563,1,Administration site swelling,Administration site reactions NEC,Administration site reactions,Genrl,N
564,1,HIV infection,Retroviral infections,Viral infectious disorders,Infec,N
565,1,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
565,2,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
565,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
565,4,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
565,5,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
565,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
565,7,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
566,1,Injection site induration,Injection site reactions,Administration site reactions,Genrl,N
566,2,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
566,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
567,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
567,2,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
568,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
569,1,Apathy,Mood disorders NEC,Mood disorders and disturbances NEC,Psych,N
569,2,Decreased interest,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
569,3,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
569,4,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
569,5,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
569,6,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
570,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
570,2,Schizophrenia,Schizophrenia NEC,Schizophrenia and other psychotic disorders,Psych,N
571,1,Nasal congestion,Nasal congestion and inflammations,Upper respiratory tract disorders (excl infections),Resp,N
572,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
573,1,Blood prolactin increased,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
574,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
574,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
574,3,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
575,1,Arrhythmia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,Y
575,2,Left ventricular failure,Left ventricular failures,Heart failures,Card,N
576,1,Mental impairment,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
577,1,Lung cancer metastatic,Respiratory tract and pleural neoplasms malignant cell type unspecified NEC,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
578,1,Mental impairment,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
578,2,Pressure of speech,Speech articulation and rhythm disturbances,Communication disorders and disturbances,Psych,N
578,3,Tachyphrenia,Thinking disturbances,Disturbances in thinking and perception,Psych,N
579,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
579,2,Schizophrenia,Schizophrenia NEC,Schizophrenia and other psychotic disorders,Psych,N
580,1,Blood prolactin increased,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
581,1,Dystonia,Dystonias,Movement disorders (incl parkinsonism),Nerv,N
581,2,Eye movement disorder,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
581,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
582,1,Alcohol abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
582,2,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
582,3,Schizophrenia,Schizophrenia NEC,Schizophrenia and other psychotic disorders,Psych,N
582,4,Self-destructive behaviour,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
583,1,Blood prolactin increased,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
583,2,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
584,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
584,2,Gender dysphoria,Sexual and gender identity disorders NEC,"Sexual dysfunctions, disturbances and gender identity disorders",Psych,N
585,1,Autism spectrum disorder,Pervasive developmental disorders NEC,Developmental disorders NEC,Psych,N
585,2,Mood altered,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
585,3,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
586,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
586,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
586,3,Syringe issue,Device physical property and chemical issues,Device issues,Prod,N
587,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
587,2,Mania,Mood alterations with manic symptoms,Manic and bipolar mood disorders and disturbances,Psych,N
588,1,Bipolar disorder,Bipolar disorders,Manic and bipolar mood disorders and disturbances,Psych,N
588,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
588,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
589,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
589,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
590,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
590,2,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
591,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
591,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
591,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
591,4,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
592,1,Bipolar disorder,Bipolar disorders,Manic and bipolar mood disorders and disturbances,Psych,N
592,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
592,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
593,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
593,2,Neuroleptic malignant syndrome,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
593,3,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
594,1,Schizophrenia,Schizophrenia NEC,Schizophrenia and other psychotic disorders,Psych,N
595,1,Bipolar disorder,Bipolar disorders,Manic and bipolar mood disorders and disturbances,Psych,N
595,2,Blood prolactin increased,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
595,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
595,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
596,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
596,2,Schizoaffective disorder,Schizoaffective and schizophreniform disorders,Schizophrenia and other psychotic disorders,Psych,N
597,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
597,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
597,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
597,4,Schizoaffective disorder,Schizoaffective and schizophreniform disorders,Schizophrenia and other psychotic disorders,Psych,N
598,1,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
599,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
599,2,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
599,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
599,4,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
599,5,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
599,6,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
600,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
600,2,Intestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
600,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
600,4,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
600,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
601,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
601,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
601,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
601,4,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
602,1,Hyperprolactinaemia,Anterior pituitary hyperfunction,Hypothalamus and pituitary gland disorders,Endo,N
603,1,Blood prolactin increased,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
603,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
603,3,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
604,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
605,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
605,2,Sedation,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
605,3,Tardive dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
606,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
607,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
607,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
608,1,Polyuria,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
609,1,Muscle mass,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
610,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
611,1,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
611,2,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
611,3,Portal vein thrombosis,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
611,4,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
611,5,Pulseless electrical activity,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
612,1,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
613,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
613,2,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
613,3,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
614,1,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
614,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
615,1,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,Y
616,1,Diabetic ketoacidosis,Diabetic complications NEC,Diabetic complications,Metab,N
617,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
617,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
617,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
617,4,Transient ischaemic attack,Transient cerebrovascular events,Central nervous system vascular disorders,Nerv,N
618,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
619,1,Schizophrenia,Schizophrenia NEC,Schizophrenia and other psychotic disorders,Psych,N
620,1,Injection site abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
621,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
622,1,Injection site abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
622,2,Injection site discolouration,Injection site reactions,Administration site reactions,Genrl,N
622,3,Injection site scar,Injection site reactions,Administration site reactions,Genrl,N
623,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
624,1,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
624,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
624,3,Schizophrenia,Schizophrenia NEC,Schizophrenia and other psychotic disorders,Psych,N
625,1,Completed suicide,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,Y
626,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
626,2,Hyperprolactinaemia,Anterior pituitary hyperfunction,Hypothalamus and pituitary gland disorders,Endo,N
627,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
628,1,Schizophrenia,Schizophrenia NEC,Schizophrenia and other psychotic disorders,Psych,N
629,1,Schizophrenia,Schizophrenia NEC,Schizophrenia and other psychotic disorders,Psych,N
630,1,Anhedonia,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
630,2,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
631,1,Hyperprolactinaemia,Anterior pituitary hyperfunction,Hypothalamus and pituitary gland disorders,Endo,N
631,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
631,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
632,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
632,2,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
633,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
633,2,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
634,1,Breast enlargement,Breast disorders NEC,Breast disorders,Repro,N
634,2,Menstrual disorder,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
635,1,Schizophrenia,Schizophrenia NEC,Schizophrenia and other psychotic disorders,Psych,N
636,1,Amenorrhoea,Menstruation with decreased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
636,2,Blood prolactin increased,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
637,1,Blood prolactin increased,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
637,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
638,1,Blood prolactin increased,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
638,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
639,1,Blood prolactin increased,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
639,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
640,1,Schizoaffective disorder,Schizoaffective and schizophreniform disorders,Schizophrenia and other psychotic disorders,Psych,N
640,2,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
641,1,Blood prolactin increased,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
641,2,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
642,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
643,1,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
644,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
644,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
645,1,Abnormal weight gain,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
645,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
645,3,Gynaecomastia,Breast disorders NEC,Breast disorders,Repro,N
645,4,Sedation,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
645,5,Urinary incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
646,1,Abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
646,2,Hypokinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
646,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
646,4,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
647,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
648,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
648,2,"Hallucination, auditory",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
648,3,Intentional self-injury,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
649,1,Heavy menstrual bleeding,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
650,1,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
651,1,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
651,2,Facial paralysis,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
651,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
651,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
651,5,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
652,1,Bipolar disorder,Bipolar disorders,Manic and bipolar mood disorders and disturbances,Psych,N
652,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
652,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
652,4,Schizophrenia,Schizophrenia NEC,Schizophrenia and other psychotic disorders,Psych,N
652,5,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
653,1,Blood creatinine abnormal,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
653,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
654,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
654,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
654,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
654,4,Refusal of treatment by patient,Social issues NEC,Lifestyle issues,SocCi,N
655,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
655,2,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
655,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
656,1,Dystonia,Dystonias,Movement disorders (incl parkinsonism),Nerv,N
657,1,Anorgasmia,Orgasmic disorders and disturbances,"Sexual dysfunctions, disturbances and gender identity disorders",Psych,N
657,2,Ejaculation failure,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
657,3,Hyperprolactinaemia,Anterior pituitary hyperfunction,Hypothalamus and pituitary gland disorders,Endo,N
658,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
659,1,Injection site abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
660,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
661,1,Antipsychotic drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
661,2,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
661,3,Cerebral ischaemia,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
661,4,Mental impairment,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
661,5,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
661,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
661,7,Sedation,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
661,8,Substance abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
661,9,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
661,10,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
662,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
663,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
664,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
664,2,Galactorrhoea,Lactation disorders,Breast disorders,Repro,N
664,3,Hyperprolactinaemia,Anterior pituitary hyperfunction,Hypothalamus and pituitary gland disorders,Endo,N
665,1,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
665,2,Psychiatric decompensation,Psychiatric symptoms NEC,Psychiatric and behavioural symptoms NEC,Psych,N
666,1,Acute psychosis,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
666,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
667,1,Abnormal weight gain,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
667,2,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
667,3,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
667,4,Bronchitis,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
667,5,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
667,6,Dental caries,Dental and periodontal infections and inflammations,Dental and gingival conditions,Gastr,N
667,7,Headache,Headaches NEC,Headaches,Nerv,N
667,8,Increased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
667,9,Toothache,Dental pain and sensation disorders,Dental and gingival conditions,Gastr,N
668,1,Schizophrenia,Schizophrenia NEC,Schizophrenia and other psychotic disorders,Psych,N
669,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
669,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
670,1,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
671,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
672,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
673,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
674,1,Coagulopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
674,2,Diverticulitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
674,3,Pulmonary mass,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
674,4,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
675,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
675,2,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
676,1,Muscle rigidity,Muscle tone abnormalities,Muscle disorders,Musc,N
676,2,Neuroleptic malignant syndrome,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
676,3,Trismus,Muscle tone abnormalities,Muscle disorders,Musc,N
677,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
677,2,Headache,Headaches NEC,Headaches,Nerv,N
677,3,Male sexual dysfunction,Sexual function and fertility disorders NEC,Sexual function and fertility disorders,Repro,N
677,4,Muscle disorder,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
678,1,Psychotic symptom,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
679,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
679,2,Schizophrenia,Schizophrenia NEC,Schizophrenia and other psychotic disorders,Psych,N
680,1,Breast abscess,Breast infections,Infections - pathogen unspecified,Infec,N
681,1,Breast pain,Breast signs and symptoms,Breast disorders,Repro,N
681,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
682,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
683,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
683,2,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
683,3,Injection site warmth,Injection site reactions,Administration site reactions,Genrl,N
684,1,Tardive dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
685,1,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
686,1,Bundle branch block right,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
687,1,Aplastic anaemia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
688,1,Psychotic symptom,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
689,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
690,1,Abnormal weight gain,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
690,2,Apathy,Mood disorders NEC,Mood disorders and disturbances NEC,Psych,N
690,3,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
690,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
691,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
691,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
691,3,Psychotic symptom,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
692,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
692,2,Psychotic symptom,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
693,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,Y
694,1,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
694,2,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
695,1,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
696,1,Atrial flutter,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
696,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
697,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
697,2,Gastrointestinal hypomotility,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
697,3,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
697,4,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
698,1,Body mass index decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
698,2,Eating disorder,Eating disorders NEC,Eating disorders and disturbances,Psych,N
698,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
699,1,HIV infection,Retroviral infections,Viral infectious disorders,Infec,N
700,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
701,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
701,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
702,1,Localised infection,Infections NEC,Infections - pathogen unspecified,Infec,N
702,2,Lower limb fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
703,1,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
703,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
703,3,Schizophrenia,Schizophrenia NEC,Schizophrenia and other psychotic disorders,Psych,N
704,1,Blood prolactin increased,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
704,2,Breast abscess,Breast infections,Infections - pathogen unspecified,Infec,N
705,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
705,2,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
705,3,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
706,1,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
706,2,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
706,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
706,4,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
706,5,Sinus tachycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
707,1,Cardiac discomfort,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
707,2,Cardiac flutter,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
707,3,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
707,4,Heart rate irregular,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
708,1,Bundle branch block left,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
708,2,Ejaculation failure,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
708,3,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
708,4,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
709,1,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
709,2,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
709,3,Extrapyramidal disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
709,4,Parkinsonism,Parkinson's disease and parkinsonism,Movement disorders (incl parkinsonism),Nerv,N
709,5,Salivary hypersecretion,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
710,1,Hypothermia,Body temperature altered,Body temperature conditions,Genrl,N
711,1,Dystonia,Dystonias,Movement disorders (incl parkinsonism),Nerv,N
711,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
712,1,Nephropathy,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
712,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
712,3,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
713,1,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
714,1,Dystonia,Dystonias,Movement disorders (incl parkinsonism),Nerv,N
715,1,Myocarditis,Noninfectious myocarditis,Myocardial disorders,Card,N
716,1,Injection site oedema,Injection site reactions,Administration site reactions,Genrl,N
717,1,Inappropriate antidiuretic hormone secretion,Posterior pituitary disorders,Hypothalamus and pituitary gland disorders,Endo,N
718,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
718,2,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
719,1,Schizophrenia,Schizophrenia NEC,Schizophrenia and other psychotic disorders,Psych,N
720,1,Neuroleptic malignant syndrome,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
721,1,Abnormal weight gain,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
721,2,Blood prolactin increased,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
721,3,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
722,1,Atonic seizures,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
722,2,Deafness,Hearing losses,Hearing disorders,Ear,N
722,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
722,4,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
722,5,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
723,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
723,2,Mental status changes,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
723,3,Parkinsonism,Parkinson's disease and parkinsonism,Movement disorders (incl parkinsonism),Nerv,N
723,4,Restless legs syndrome,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
723,5,Tardive dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
723,6,Transient ischaemic attack,Transient cerebrovascular events,Central nervous system vascular disorders,Nerv,N
724,1,Inflammation,Inflammations,General system disorders NEC,Genrl,N
724,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
724,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
725,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
726,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
726,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
727,1,Blepharospasm,Eyelid movement disorders,Ocular neuromuscular disorders,Eye,N
727,2,Dystonia,Dystonias,Movement disorders (incl parkinsonism),Nerv,N
727,3,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
728,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
728,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
728,3,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
728,4,Type 2 diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
729,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
729,2,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
729,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
729,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
729,5,Labelled drug-disease interaction medication error,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
730,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
730,2,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
730,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
731,1,Orthostatic hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
732,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
732,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
732,3,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
733,1,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
733,2,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
734,1,Libido decreased,Sexual desire disorders,"Sexual dysfunctions, disturbances and gender identity disorders",Psych,N
734,2,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
735,1,Extrapyramidal disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
736,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
736,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
737,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
737,2,Schizophrenia,Schizophrenia NEC,Schizophrenia and other psychotic disorders,Psych,N
738,1,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
738,2,Schizophrenia,Schizophrenia NEC,Schizophrenia and other psychotic disorders,Psych,N
738,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
738,4,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
739,1,Schizophrenia,Schizophrenia NEC,Schizophrenia and other psychotic disorders,Psych,N
740,1,Hyperprolactinaemia,Anterior pituitary hyperfunction,Hypothalamus and pituitary gland disorders,Endo,N
740,2,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
740,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
741,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
741,2,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
742,1,Intentional overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
743,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
743,2,Renal cyst,Renal neoplasms,Renal disorders (excl nephropathies),Renal,N
744,1,Intentional overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
744,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
744,3,Suicide attempt,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
745,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
745,2,Schizophrenia,Schizophrenia NEC,Schizophrenia and other psychotic disorders,Psych,N
746,1,Gynaecomastia,Breast disorders NEC,Breast disorders,Repro,N
746,2,Schizophrenia,Schizophrenia NEC,Schizophrenia and other psychotic disorders,Psych,N
747,1,Schizophrenia,Schizophrenia NEC,Schizophrenia and other psychotic disorders,Psych,N
748,1,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
748,2,Schizophrenia,Schizophrenia NEC,Schizophrenia and other psychotic disorders,Psych,N
749,1,Bradykinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
749,2,"Hallucination, auditory",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
749,3,Schizophrenia,Schizophrenia NEC,Schizophrenia and other psychotic disorders,Psych,N
749,4,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
750,1,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
751,1,Ejaculation failure,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
752,1,"Hallucination, auditory",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
752,2,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
753,1,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
753,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
753,3,Schizophrenia,Schizophrenia NEC,Schizophrenia and other psychotic disorders,Psych,N
754,1,Abnormal dreams,Parasomnias,Sleep disorders and disturbances,Psych,N
754,2,Abnormal weight gain,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
754,3,Weight loss poor,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
755,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
755,2,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
756,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
756,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
756,3,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
756,4,Procedural pain,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
756,5,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
756,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
757,1,Intentional overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
757,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
757,3,Suicide attempt,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
758,1,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
759,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
760,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
761,1,Administration site swelling,Administration site reactions NEC,Administration site reactions,Genrl,N
762,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
762,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
762,3,Muscle injury,"Muscle, tendon and ligament injuries",Injuries NEC,Inj&P,N
762,4,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
762,5,Nerve injury,Nerve injuries NEC,Injuries NEC,Inj&P,N
762,6,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
763,1,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
763,2,Cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
763,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
764,1,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
764,2,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
764,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
764,4,Liquid product physical issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
764,5,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
765,1,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
766,1,Dementia Alzheimer's type,Alzheimer's disease (incl subtypes),Mental impairment disorders,Nerv,N
766,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
767,1,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
767,2,Nervous system disorder,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
767,3,Schizophrenia,Schizophrenia NEC,Schizophrenia and other psychotic disorders,Psych,N
768,1,Schizophrenia,Schizophrenia NEC,Schizophrenia and other psychotic disorders,Psych,N
769,1,Retching,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
770,1,Retching,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
771,1,Dementia Alzheimer's type,Alzheimer's disease (incl subtypes),Mental impairment disorders,Nerv,N
772,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
772,2,Headache,Headaches NEC,Headaches,Nerv,N
772,3,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
772,4,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
773,1,Dementia Alzheimer's type,Alzheimer's disease (incl subtypes),Mental impairment disorders,Nerv,N
774,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
775,1,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
775,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
775,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
775,4,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
776,1,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
776,2,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
777,1,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
777,2,Injection site warmth,Injection site reactions,Administration site reactions,Genrl,N
778,1,Blood prolactin increased,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
779,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
780,1,Hyperprolactinaemia,Anterior pituitary hyperfunction,Hypothalamus and pituitary gland disorders,Endo,N
781,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
781,2,Injury,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
781,3,Musculoskeletal injury,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
781,4,Neuroleptic malignant syndrome,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
782,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
782,2,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
782,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
782,4,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
783,1,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
783,2,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
783,3,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
784,1,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
785,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
785,2,Extrapyramidal disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
785,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
785,4,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
786,1,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
787,1,Apathy,Mood disorders NEC,Mood disorders and disturbances NEC,Psych,N
787,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
787,3,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
788,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
788,2,Neuroleptic malignant syndrome,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
789,1,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
790,1,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
791,1,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
791,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
792,1,Abnormal weight gain,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
793,1,Priapism,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
794,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
794,2,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
795,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
796,1,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
797,1,Tardive dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
798,1,Abnormal weight gain,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
798,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
798,3,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
798,4,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
798,5,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
798,6,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
798,7,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
798,8,Ligament pain,Ligament disorders,"Tendon, ligament and cartilage disorders",Musc,N
798,9,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
799,1,Myelopathy,Spinal cord and nerve root disorders NEC,Spinal cord and nerve root disorders,Nerv,N
800,1,Ejaculation failure,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
801,1,Extrapyramidal disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
802,1,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
803,1,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
804,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
804,2,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
805,1,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
806,1,Inflammation,Inflammations,General system disorders NEC,Genrl,N
807,1,Ejaculation failure,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
808,1,Extrapyramidal disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
809,1,Administration site fibrosis,Administration site reactions NEC,Administration site reactions,Genrl,N
810,1,"Hallucination, auditory",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
811,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
812,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
813,1,Amenorrhoea,Menstruation with decreased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
813,2,Blood prolactin increased,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
814,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
814,2,Priapism,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
814,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
815,1,Blood prolactin increased,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
816,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
817,1,Gynaecomastia,Breast disorders NEC,Breast disorders,Repro,N
817,2,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
818,1,Blood prolactin increased,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
819,1,Blood prolactin increased,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
820,1,Blood prolactin increased,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
821,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
822,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
823,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
824,1,Schizophrenia,Schizophrenia NEC,Schizophrenia and other psychotic disorders,Psych,N
825,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
826,1,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
827,1,Anion gap increased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
827,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
828,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
829,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
830,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
831,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
832,1,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
832,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
832,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
833,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
834,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
835,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
835,2,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
835,3,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
836,1,Abnormal weight gain,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
837,1,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
838,1,Tardive dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
839,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
840,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
841,1,Dystonia,Dystonias,Movement disorders (incl parkinsonism),Nerv,N
841,2,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
842,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
843,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
844,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
845,1,Logorrhoea,Speech and language usage disturbances,Communication disorders and disturbances,Psych,N
846,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
847,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
848,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
849,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
850,1,Tardive dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
851,1,Urinary incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
852,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
853,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
854,1,Incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
855,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
855,2,Oculogyric crisis,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
856,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
856,2,Vascular dementia,Dementia (excl Alzheimer's type),Mental impairment disorders,Nerv,N
857,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
858,1,Therapy cessation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
859,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
860,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
861,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
862,1,Refusal of treatment by patient,Social issues NEC,Lifestyle issues,SocCi,N
863,1,Device leakage,Device issues NEC,Device issues,Prod,N
863,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
864,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
864,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
865,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
865,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
865,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
866,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
867,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
868,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
868,2,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
868,3,Malabsorption,Malabsorption syndromes,Malabsorption conditions,Gastr,N
868,4,Muscle atrophy,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
869,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
870,1,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
870,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
870,3,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
870,4,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
870,5,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
871,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
871,2,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
871,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
872,1,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
873,1,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
874,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
874,2,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
875,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
876,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
877,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
878,1,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
879,1,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
879,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
879,3,Schizophrenia,Schizophrenia NEC,Schizophrenia and other psychotic disorders,Psych,N
880,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
881,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
881,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
881,3,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
882,1,Injection site nodule,Injection site reactions,Administration site reactions,Genrl,N
883,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
883,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
884,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
885,1,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
886,1,Schizophrenia,Schizophrenia NEC,Schizophrenia and other psychotic disorders,Psych,N
887,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
888,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
889,1,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
890,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
891,1,Refusal of treatment by patient,Social issues NEC,Lifestyle issues,SocCi,N
892,1,Refusal of treatment by patient,Social issues NEC,Lifestyle issues,SocCi,N
893,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
894,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
895,1,Blood prolactin increased,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
895,2,Sexual dysfunction,Sexual function and fertility disorders NEC,Sexual function and fertility disorders,Repro,N
896,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
896,2,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
897,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
898,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
898,2,Hangover,Feelings and sensations NEC,General system disorders NEC,Genrl,N
898,3,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
899,1,Breast cancer metastatic,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,Y
900,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
901,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
902,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
903,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
903,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,Y
904,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
905,1,Increased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
906,1,Ejaculation disorder,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
907,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
907,2,Sexual dysfunction,Sexual function and fertility disorders NEC,Sexual function and fertility disorders,Repro,N
908,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
909,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
910,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
911,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
912,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
913,1,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
914,1,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
915,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
916,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
917,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
918,1,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
919,1,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
920,1,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
921,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
922,1,Drug level above therapeutic,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
922,2,Muscle rigidity,Muscle tone abnormalities,Muscle disorders,Musc,N
922,3,Salivary hypersecretion,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
923,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
923,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
924,1,Expired product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
925,1,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
926,1,Sexual dysfunction,Sexual function and fertility disorders NEC,Sexual function and fertility disorders,Repro,N
927,1,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
928,1,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
929,1,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
930,1,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
931,1,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
932,1,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
933,1,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
934,1,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
935,1,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
936,1,Wrong patient received product,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
937,1,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
938,1,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
939,1,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
940,1,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
941,1,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
942,1,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
943,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
944,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
945,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
946,1,Intercepted product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
946,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
947,1,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
948,1,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
949,1,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
950,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
951,1,Refusal of treatment by patient,Social issues NEC,Lifestyle issues,SocCi,N
952,1,Akathisia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
952,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
952,3,Extrapyramidal disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
953,1,Refusal of treatment by patient,Social issues NEC,Lifestyle issues,SocCi,N
954,1,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
955,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
955,2,Incoherent,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
955,3,Penis disorder,Penile disorders NEC (excl erection and ejaculation),Penile and scrotal disorders (excl infections and inflammations),Repro,N
956,1,Psychotic symptom,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
956,2,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
957,1,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
957,2,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
958,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
958,2,Mixed incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
958,3,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
959,1,Agranulocytosis,Neutropenias,White blood cell disorders,Blood,N
959,2,Akathisia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
959,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
959,4,Extrapyramidal disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
959,5,Extrapyramidal disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
960,1,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
961,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
962,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
963,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
964,1,Loss of libido,Sexual desire disorders,"Sexual dysfunctions, disturbances and gender identity disorders",Psych,N
964,2,Sedation,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
964,3,Sexual dysfunction,Sexual function and fertility disorders NEC,Sexual function and fertility disorders,Repro,N
964,4,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
965,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
965,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
965,3,Glossodynia,Tongue signs and symptoms,Tongue conditions,Gastr,N
965,4,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
965,5,Product monitoring error,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
965,6,Urinary incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
966,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
967,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
968,1,Refusal of treatment by patient,Social issues NEC,Lifestyle issues,SocCi,N
969,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
970,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
971,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
972,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
973,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
973,2,Tension,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
974,1,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
975,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
975,2,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
976,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
977,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
977,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
978,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
978,2,Priapism,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
979,1,Blood prolactin increased,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
980,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
981,1,Intentional overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,Y
982,1,Hepatic enzyme increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
983,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
983,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
984,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
985,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
986,1,Antipsychotic drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
986,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
986,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
986,4,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
986,5,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
986,6,Salivary hypersecretion,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
987,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
988,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
989,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
989,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
989,3,Salivary hypersecretion,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
989,4,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
990,1,Respiratory arrest,Breathing abnormalities,Respiratory disorders NEC,Resp,Y
991,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
992,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
993,1,Loss of libido,Sexual desire disorders,"Sexual dysfunctions, disturbances and gender identity disorders",Psych,N
994,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
995,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
995,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
995,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
995,4,Salivary hypersecretion,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
996,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
996,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
997,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
997,2,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
997,3,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
998,1,Salivary hypersecretion,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
999,1,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
1000,1,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
1001,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1001,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1002,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1003,1,Device leakage,Device issues NEC,Device issues,Prod,N
1003,2,Drug delivery system malfunction,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1003,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1004,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1005,1,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
1006,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1007,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1008,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1009,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1010,1,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1011,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
1011,2,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1011,3,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
1011,4,Tearfulness,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
1012,1,Device issue,Device issues NEC,Device issues,Prod,N
1012,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1012,3,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1013,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1014,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1014,2,Pemphigoid,Bullous conditions,Epidermal and dermal conditions,Skin,N
1015,1,Tardive dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
1016,1,Neuroleptic malignant syndrome,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
1017,1,Pemphigoid,Bullous conditions,Epidermal and dermal conditions,Skin,N
1018,1,Pemphigoid,Bullous conditions,Epidermal and dermal conditions,Skin,N
1019,1,Pemphigoid,Bullous conditions,Epidermal and dermal conditions,Skin,N
1020,1,Pemphigoid,Bullous conditions,Epidermal and dermal conditions,Skin,N
1021,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1022,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1023,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1024,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1024,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1025,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1025,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1025,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1026,1,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
1026,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1026,3,Neuroleptic malignant syndrome,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
1026,4,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1027,1,Refusal of treatment by patient,Social issues NEC,Lifestyle issues,SocCi,N
1028,1,Pemphigoid,Bullous conditions,Epidermal and dermal conditions,Skin,N
1029,1,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
1029,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1029,3,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1030,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1031,1,Rehabilitation therapy,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
1032,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1033,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1033,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1034,1,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1035,1,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1035,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1036,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1037,1,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1037,2,Salivary hypersecretion,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
1038,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1039,1,Glaucoma,Glaucomas (excl congenital),Glaucoma and ocular hypertension,Eye,N
1040,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1041,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1042,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1042,2,Apathy,Mood disorders NEC,Mood disorders and disturbances NEC,Psych,N
1042,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1042,4,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1043,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
1043,2,Delusion,Delusional symptoms,Disturbances in thinking and perception,Psych,N
1043,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1044,1,Vomiting projectile,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1045,1,Delusion of grandeur,Delusional symptoms,Disturbances in thinking and perception,Psych,N
1045,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1045,3,Overweight,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
1045,4,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1046,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1047,1,Enuresis,Psychiatric elimination disorders,Psychiatric disorders NEC,Psych,N
1048,1,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
1049,1,Gynaecomastia,Breast disorders NEC,Breast disorders,Repro,N
1049,2,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1049,3,Metabolic disorder,Metabolic disorders NEC,Metabolism disorders NEC,Metab,N
1049,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1049,5,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1050,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1051,1,Depression suicidal,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1051,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1052,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1053,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1053,2,Syringe issue,Device physical property and chemical issues,Device issues,Prod,N
1054,1,Apathy,Mood disorders NEC,Mood disorders and disturbances NEC,Psych,N
1054,2,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1055,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1056,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1057,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1058,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1059,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1060,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1061,1,Anhedonia,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
1061,2,Apathy,Mood disorders NEC,Mood disorders and disturbances NEC,Psych,N
1061,3,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1061,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1061,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1062,1,Palliative care,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
1063,1,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1063,2,Sinus headache,Headaches NEC,Headaches,Nerv,N
1063,3,Sleep apnoea syndrome,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1064,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
1064,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1064,3,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1064,4,Emotional poverty,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1064,5,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
1064,6,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
1064,7,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1064,8,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
1064,9,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1065,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1065,2,Needle issue,Device physical property and chemical issues,Device issues,Prod,N
1065,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1065,4,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1066,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1067,1,Extrapyramidal disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
1067,2,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
1067,3,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1068,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1068,2,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
1069,1,Post procedural complication,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
1070,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1071,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1072,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1072,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1072,3,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1073,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1074,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1075,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1075,2,Extrapyramidal disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
1075,3,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1075,4,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1076,1,Muscle disorder,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1077,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1077,2,Mental impairment,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1077,3,Psychotic symptom,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
1078,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1079,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1080,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1081,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1082,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1083,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1084,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1085,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1085,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1086,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1087,1,Akathisia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
1087,2,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1088,1,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
1089,1,Abnormal weight gain,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
1089,2,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1089,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1089,4,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1089,5,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
1089,6,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1089,7,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
1090,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1091,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1092,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1093,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1094,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1095,1,Metabolic syndrome,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1095,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1096,1,Metabolic syndrome,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1096,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1097,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1098,1,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
1099,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1100,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1101,1,Therapy partial responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1102,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
1103,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1104,1,Metabolic syndrome,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1104,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1105,1,Lip pruritus,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
1105,2,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
1106,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1107,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1108,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1108,2,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
1109,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
1109,2,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1110,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1110,2,Emotional disorder,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1110,3,Mania,Mood alterations with manic symptoms,Manic and bipolar mood disorders and disturbances,Psych,N
1111,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1111,2,Heart rate decreased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
1111,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1111,4,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
1112,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1113,1,Overweight,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
1114,1,Social avoidant behaviour,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
1115,1,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
